We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.95T
$1.28B 7.41%
2,582,927
-68,980
-3% -$30M
NVDA icon
2
NVIDIA
NVDA
$5.02T
$1.17B 6.77%
7,427,994
+82,234
+1% +$10.3M
AAPL icon
3
Apple
AAPL
$4.81T
$701M 4.04%
3,416,085
+7,469
+0.2% +$1.51M
AMZN icon
4
Amazon
AMZN
$2.66T
$481M 2.78%
2,194,306
+121,364
+6% +$24M
AVGO icon
5
Broadcom
AVGO
$1.84T
$432M 2.49%
1,567,258
+391,447
+33% +$85M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.24T
$411M 2.37%
2,333,489
-333,092
-12% -$54.5M
LLY icon
7
Eli Lilly
LLY
$1.05T
$359M 2.07%
460,808
-20,046
-4% -$15.6M
META icon
8
Meta Platforms (Facebook)
META
$1.63T
$264M 1.52%
357,909
-20,820
-5% -$12.9M
MA icon
9
Mastercard
MA
$476B
$250M 1.44%
444,555
-21,959
-5% -$12.1M
CRM icon
10
Salesforce
CRM
$139B
$204M 1.18%
747,535
+23,308
+3% +$6.23M
JPM icon
11
JPMorgan Chase
JPM
$918B
$199M 1.15%
687,449
-76,860
-10% -$19.6M
TSM icon
12
TSMC
TSM
$2.2T
$195M 1.12%
861,029
-61,323
-7% -$11.4M
ISRG icon
13
Intuitive Surgical
ISRG
$124B
$181M 1.05%
333,546
-16,385
-5% -$8.57M
V icon
14
Visa
V
$677B
$178M 1.03%
501,341
-32,688
-6% -$11.4M
PG icon
15
Procter & Gamble
PG
$345B
$174M 1%
1,092,698
-219,842
-17% -$35.9M
GOOG icon
16
Alphabet (Google) Class C
GOOG
$4.22T
$169M 0.97%
950,766
+35,977
+4% +$5.95M
GILD icon
17
Gilead Sciences
GILD
$162B
$167M 0.97%
1,509,838
-64,606
-4% -$6.88M
PANW icon
18
Palo Alto Networks
PANW
$279B
$166M 0.96%
810,897
+15,204
+2% +$2.82M
WM icon
19
Waste Management
WM
$93.6B
$149M 0.86%
650,705
-124,724
-16% -$28.9M
ABT icon
20
Abbott
ABT
$174B
$142M 0.82%
1,046,883
+407,813
+64% +$53.8M
AMGN icon
21
Amgen
AMGN
$198B
$141M 0.81%
505,720
-483
-0.1% -$137K
TMO icon
22
Thermo Fisher Scientific
TMO
$195B
$137M 0.79%
337,473
-84,881
-20% -$35.5M
MRK icon
23
Merck
MRK
$312B
$131M 0.76%
1,654,099
-494,389
-23% -$39.3M
NOW icon
24
ServiceNow
NOW
$105B
$127M 0.73%
619,835
+5,115
+0.8% +$965K
EMR icon
25
Emerson Electric
EMR
$78B
$122M 0.7%
912,975
-133,344
-13% -$15.3M

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.